These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 31819956

  • 1. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.
    Mukhopadhyay S, Heinz E, Porreca I, Alasoo K, Yeung A, Yang HT, Schwerd T, Forbester JL, Hale C, Agu CA, Choi YH, Rodrigues J, Capitani M, Jostins-Dean L, Thomas DC, Travis S, Gaffney D, Skarnes WC, Thomson N, Uhlig HH, Dougan G, Powrie F.
    J Exp Med; 2020 Feb 03; 217(2):. PubMed ID: 31819956
    [Abstract] [Full Text] [Related]

  • 2. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.
    Lin Z, Wang Z, Hegarty JP, Lin TR, Wang Y, Deiling S, Wu R, Thomas NJ, Floros J.
    World J Gastroenterol; 2017 Jul 21; 23(27):4897-4909. PubMed ID: 28785144
    [Abstract] [Full Text] [Related]

  • 3. Knockout-Induced Pluripotent Stem Cells for Disease and Therapy Modeling of IL-10-Associated Primary Immunodeficiencies.
    Sens J, Hoffmann D, Lange L, Vollmer Barbosa P, Morgan M, Falk CS, Schambach A.
    Hum Gene Ther; 2021 Jan 21; 32(1-2):77-95. PubMed ID: 33023317
    [Abstract] [Full Text] [Related]

  • 4. [Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis].
    Lu D, Xu Y, Chen Y, Zeng P, Chen H, Zeng H.
    Zhonghua Er Ke Za Zhi; 2015 May 21; 53(5):348-54. PubMed ID: 26080664
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Very early onset inflammatory bowel disease: Investigation of the IL-10 signaling pathway in Iranian children.
    Nemati S, Teimourian S, Tabrizi M, Najafi M, Dara N, Imanzadeh F, Ahmadi M, Aghdam MK, Tavassoli M, Rohani P, Madani SR, de Boer M, Kuijpers TW, Roos D.
    Eur J Med Genet; 2017 Dec 21; 60(12):643-649. PubMed ID: 28864178
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Activation, cytokine production, and intracellular survival of bacteria in Salmonella-infected human monocyte-derived macrophages and dendritic cells.
    Pietilä TE, Veckman V, Kyllönen P, Lähteenmäki K, Korhonen TK, Julkunen I.
    J Leukoc Biol; 2005 Oct 21; 78(4):909-20. PubMed ID: 16033811
    [Abstract] [Full Text] [Related]

  • 12. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.
    Beser OF, Conde CD, Serwas NK, Cokugras FC, Kutlu T, Boztug K, Erkan T.
    J Pediatr Gastroenterol Nutr; 2015 Mar 21; 60(3):332-8. PubMed ID: 25373860
    [Abstract] [Full Text] [Related]

  • 13. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK, Cho W, Sung SH, Lee KT.
    J Pharmacol Exp Ther; 2012 Sep 21; 342(3):654-64. PubMed ID: 22637723
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced PMA enhances the responsiveness of transfected THP-1 macrophages to polarizing stimuli.
    Maeß MB, Wittig B, Cignarella A, Lorkowski S.
    J Immunol Methods; 2014 Jan 15; 402(1-2):76-81. PubMed ID: 24269601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy.
    Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, Pfeifer D, Kreipe H, Pfister ED, Baumann U, Puchalka J, Bohne J, Egritas O, Dalgic B, Kolho KL, Sauerbrey A, Buderus S, Güngör T, Enninger A, Koda YK, Guariso G, Weiss B, Corbacioglu S, Socha P, Uslu N, Metin A, Wahbeh GT, Husain K, Ramadan D, Al-Herz W, Grimbacher B, Sauer M, Sykora KW, Koletzko S, Klein C.
    Gastroenterology; 2012 Aug 15; 143(2):347-55. PubMed ID: 22549091
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.